Taltz 80 MG/ML autoinjectorml
Ended Awarded Last action
- Contract number
- SPE2DR26F3SNK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,862
Award facts
- Contract value 100% obligated
- $10,861.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $10,861.82 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on December 30, 2025, with a completion date of December 31, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant medication used to treat autoimmune conditions including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis, representing a specialized pharmaceutical supply need within the federal medical procurement system.
This delivery order operates under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves critical federal medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F3SNK?
SPE2DR26F3SNK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26F3SNK worth?
The government has obligated $10,862 on SPE2DR26F3SNK.
Is contract SPE2DR26F3SNK an order under another contract?
Yes. SPE2DR26F3SNK is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3SNK competed?
The extent of competition for SPE2DR26F3SNK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award